A Semaine Health education guide. Reviewed against the published research; sources linked throughout. Educational content, not medical advice.
The short answer
Women make up roughly two-thirds of people living with Alzheimer's disease, and for a long time that was explained away by the fact that women live longer. Longevity is part of it, but a comprehensive review of the sex-difference research concluded it doesn't fully account for the gap, and pointed to a mix of biological and social factors instead (Ferretti et al., 2018, Nat Rev Neurol; DOI). Two of the clearest biological threads: the menopause transition itself, when the brain's supply of estrogen declines, and a genetic risk factor that behaves differently in women than in men. This is an active and still-developing area of science, not settled fact, but it reframes brain aging in women as something that may begin decades before symptoms, during midlife.
Beyond "women just live longer"
Living longer raises lifetime risk, because age is the single biggest Alzheimer's risk factor. But researchers comparing women and men of the same age still see differences that longevity alone doesn't explain. A large study pooling brain-imaging and clinical data found that women showed a faster rate of decline in cognitive tests and greater spread of Alzheimer's-associated brain changes than men with comparable disease severity, even after accounting for age (Nebel et al., 2018, Alzheimers Dement; DOI). That's pushed attention toward risk factors men don't have, including a sharp, midlife hormonal transition that directly affects the brain.
The genetic piece: APOE4 behaves differently in women
APOE4 is the best-known genetic risk variant for Alzheimer's, and it doesn't affect men and women equally. Large cohort studies have found that women carrying one copy of APOE4 face a bigger jump in Alzheimer's risk than men carrying the same variant, an interaction that shows up specifically in a particular age window rather than across the whole lifespan (Altmann et al., 2014, Ann Neurol; DOI). Imaging studies add a mechanistic piece to this: women with amyloid plaque buildup (a hallmark of Alzheimer's pathology) tend to accumulate tau, the protein tangles more tightly linked to actual symptoms, faster than men with comparable amyloid levels, particularly around the time of menopause (Buckley et al., 2019, JAMA Neurol; DOI). In other words, a shared genetic risk factor and a shared pathological marker both seem to translate into disease faster in women, and the menopause window looks like part of why.
The menopause connection
Here's the part that's genuinely new. Brain-imaging research has identified the perimenopause-to-menopause transition as a sex-specific window when the brain's estrogen-regulated energy metabolism falters, producing measurable glucose hypometabolism, the same kind of bioenergetic change seen in brains at risk for Alzheimer's (Mosconi, Brinton et al., 2017, PLOS One; DOI). The researchers describe female sex, via this transition, as a biological risk factor in its own right, and note that the transition may be the most informative window for understanding and supporting brain health. The mechanism, estrogen as a brain regulator, is laid out in how your brain runs on estrogen.
Two cautions, because this matters. First, this is an emerging hypothesis about risk and biology, not a claim that menopause causes Alzheimer's, most women go through menopause and never develop it. Second, a bioenergetic dip during the transition is not the disease; it's a change researchers are studying as one possible piece of a complex puzzle that also includes genetics (such as APOE4), cardiovascular health, sleep, and more.
Why this is empowering, not frightening
The reframe is the opposite of fatalism. If part of women's brain-aging risk is concentrated in a known, midlife window, that's a window to pay attention to the modifiable factors that support brain health: sleep, cardiovascular and metabolic health, exercise, and managing the menopausal transition with a clinician. Understanding the biology at 45 is far more useful than reacting to symptoms at 75. Brain aging in women may start earlier than anyone told you, which also means the opportunity to support it starts earlier.
When to talk to a clinician
If you have a family history of dementia, the APOE4 gene, or you're worried about memory, talk to a clinician about your individual risk and what's worth monitoring. If you're in perimenopause and symptoms are significant, that same conversation can cover hormone therapy and overall brain-and-body health during the transition. This article is educational and not a substitute for personalized medical advice.
Frequently asked questions
Why are women more likely to get Alzheimer's?
Women are about two-thirds of cases. Greater longevity is part of it, but a review of the evidence found it doesn't fully account for the gap (Ferretti et al., 2018). Research increasingly points to a combination of the menopause transition, when the brain's estrogen supply declines, and sex differences in how genetic risk factors like APOE4 behave, as sex-specific factors in women's brain-aging risk.
Does menopause cause Alzheimer's?
No. Most women go through menopause and never develop Alzheimer's. Researchers are studying the transition as a window of changed brain risk, not as a cause. It's one emerging piece of a complex, multi-factor picture.
Is it just because women live longer?
Longevity contributes, since age is the biggest risk factor, but same-age comparisons still show differences longevity alone doesn't explain, including faster cognitive decline and broader spread of Alzheimer's-related brain changes in women (Nebel et al., 2018), which is why the menopause transition and genetic sex differences are under study.
Does the APOE4 gene affect women and men differently?
Yes. Large cohort studies have found that carrying the APOE4 variant raises Alzheimer's risk more in women than in men, in a specific age window (Altmann et al., 2014). Imaging research also suggests women with amyloid buildup develop tau pathology, the marker more closely tied to symptoms, faster than men with comparable amyloid levels (Buckley et al., 2019).
Can I lower my risk?
Risk is multi-factor and partly modifiable. Sleep, cardiovascular and metabolic health, exercise, and managing the menopausal transition with a clinician are the levers research points to. Discuss your individual risk, especially with family history or APOE4.
When does brain-aging risk start for women?
The research suggests changes can begin in midlife, during the menopause transition, decades before any symptoms, which is also why midlife is a meaningful time to support brain health.
Related reading
- How your brain runs on estrogen
- Menopause brain fog: why it happens
- Is perimenopause brain fog permanent?
References
- Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014. DOI: 10.1002/ana.24135 · PubMed
- Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol. 2019. DOI: 10.1001/jamaneurol.2018.4693 · PubMed
- Sex differences in Alzheimer disease: the gateway to precision medicine. Nat Rev Neurol. 2018. DOI: 10.1038/s41582-018-0032-9 · PubMed
- Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. PLoS One. 2017. DOI: 10.1371/journal.pone.0185926 · PubMed
- Understanding the impact of sex and gender in Alzheimer's disease: A call to action. Alzheimers Dement. 2018. DOI: 10.1016/j.jalz.2018.04.008 · PubMed
